LIPOXEN TECHNOLOGIES LIMITED

Patent Owner

Watch Compare Add to Portfolio

Stats

Details

Patent Activity in the Last 10 Years

Technologies

Intl Class Technology Matters Rank in Class
 
  
 
A61K PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES 43212
 
  
 
C07K PEPTIDES 27109
 
  
 
C08B POLYSACCHARIDES; DERIVATIVES THEREOF 1615
 
  
 
C07H SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS 1188
 
  
 
C12N MICRO-ORGANISMS OR ENZYMES; COMPOSITIONS THEREOF 6161
 
  
 
B01D SEPARATION 5129
 
  
 
A01N PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF 491
 
  
 
C12P FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE 495
 
  
 
C08H DERIVATIVES OF NATURAL MACROMOLECULAR COMPOUNDS 213

Top Patents (by citation)

Upgrade to the Professional Level to View Top Patents for this Owner. Learn More

Recent Publications

Publication # Title Filing Date Pub Date Intl Class
2017/0202,854 Method for Treatment of Primary Hormone Resistant Endometrial and Breast CancersMar 31, 17Jul 20, 17[A61K]
2017/0049,702 Method to Enhance an Immune Response of Nucleic Acid VaccinationNov 08, 16Feb 23, 17[A61K, C12N]
2015/0344,591 Sialic Acid DerivativesJul 05, 15Dec 03, 15[A61K, C08B]
2015/0307,633 Polysialic Acid DerivativesJul 05, 15Oct 29, 15[C12N, C08B, C07K]

Recent Patents

Patent # Title Filing Date Issue Date Intl Class
9920137 Polysialic acid derivativesJul 05, 15Mar 20, 18[A61K, C12N, C08B, C07K]
9828443 Fractionation of charged polysaccharideOct 27, 15Nov 28, 17[A61K, C08B, C07K, B01D]
9795683 Glycopolysialylation of non-blood coagulation proteinsJul 26, 10Oct 24, 17[A61K]
9789163 N-terminal derivatisation of proteins with polysaccharidesNov 15, 16Oct 17, 17[A61K, C12N, C07K]
9790288 Fractionation of charged polysaccharideOct 27, 15Oct 17, 17[A61K, C08B, C07K, B01D]
9750692 Liposomal vaccine compositions comprising a polysaccharide antigen and a protein adjuvantMay 07, 14Sep 05, 17[A61K]
9579393 Derivatisation of erythropoietin (EPO)Jan 19, 16Feb 28, 17[A61K, C07K]
9549990 Derivatisation of erythropoietin (EPO)Jan 19, 16Jan 24, 17[A61K, C07K]
9492556 N-terminal derivatisation of proteins with polysaccharidesFeb 04, 15Nov 15, 16[A61K, C07K]
9492557 Derivatisation of granulocyte colony-stimulating factorApr 17, 15Nov 15, 16[A61K, A01N, C07K]

View all patents..

Expired/Abandoned/Withdrawn Patents

Patent # Title Status Filing Date Issue/Pub Date Intl Class
2017/0119,893 Derivatisation of Erythropoietin (EPO)AbandonedJan 12, 17May 04, 17[A61K, A61P]
2017/0080,054 Derivatisation of Granulocyte Colony-Stimulating FactorAbandonedOct 03, 16Mar 23, 17[A61K]
2016/0175,249 Liposomes Containing Oligopeptide Fragments of Myelin Basic Protein, a Pharmaceutical Composition and a Method for Treatment of Multiple SclerosisAbandonedOct 20, 15Jun 23, 16[A61K]
2016/0081,930 Small Interfering RNA DeliveryAbandonedNov 30, 15Mar 24, 16[A61K, C12N]
2013/0058,994 LIPOSOMES CONTAINING OLIGOPEPTIDE FRAGMENTS OF MYELIN BASIC PROTEIN, A PHARMACEUTICAL COMPOSITION AND A METHOD FOR TREATMENT OF MULTIPLE SCLEROSISAbandonedApr 11, 12Mar 07, 13[A61K, B82Y, A61P, C07K]
2012/0121,689 SMALL INTERFERING RNA DELIVERYAbandonedNov 09, 09May 17, 12[A61K, B82Y, A61P]
2011/0159,130 REDUCTION OF ENDOTOXIN IN POLYSIALIC ACIDSAbandonedFeb 28, 08Jun 30, 11[A61K, C12P, C07K]
2010/0221,808 POLYSIALIC ACID DERIVATIVESAbandonedMar 03, 10Sep 02, 10[C12N, C08B]
2009/0068,254 MULTIVALENT LIPOSOMAL VACCINE COMPOSITIONS COMPRISING POLYSACCHARIDE ANTIGENS AND A PROTEIN ADJUVANTAbandonedSep 29, 06Mar 12, 09[A61K, A61P]
7008791 Liposome-entrapped DNA oral vaccinesExpiredOct 02, 00Mar 07, 06[C12N]

Top Inventors for This Owner

Upgrade to the Professional Level to View Top Inventors for this Owner. Learn More

We are sorry but your current selection exceeds the maximum number of comparisons () for this membership level. Upgrade to our Level for up to -1 comparisons!

We are sorry but your current selection exceeds the maximum number of portfolios (0) for this membership level. Upgrade to our Level for up to -1 portfolios!.